📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer. (2021)

First Author: Wang N

Attributed to: Development of an effective therapeutic regimen for treatment of advanced pancreatic cancer using a novel immunotherapeutic agent funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omto.2020.11.002

PubMed Identifier: 33575472

Publication URI: http://europepmc.org/abstract/MED/33575472

Type: Journal Article/Review

Volume: 20

Parent Publication: Molecular therapy oncolytics

ISSN: 2372-7705